Merit Medical to Present “Foundations for Growth” Program and Financial Targets for 2020 to 2023

NEXT STORY
Adaptive Biotechnologies Reports Third Quarter 2020 Financial Results
PREV STORY
TRACON Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

New Novartis Phase III data for brolucizumab demonstrate reliability of 12-week treatment interval

author_avatar
NASDAQ Market News

TYME and The Joseph Ahmed Foundation Announce Initiation of the HopES Phase II Trial Evaluating the Potential Benefits of SM-88 for Patients with High-Risk Sarcomas

author_avatar
NASDAQ Market News

Bio-Path Holdings Reports First Quarter 2017 Financial Results

HOUSTON, May 11, 2017 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH), a biotechnology company ...

author_avatar
NASDAQ Market News